FOSUN HEALTH Logo

Epilepsy Treatment

catalogue

Epilepsy Treatment

Epilepsy Treatment

Treatment for epilepsy is tried in an order, and the order matters more than the individual choices. Medication comes first, and most people become free of seizures on it, most of them on the first drug or the second. Where two properly chosen and tolerated drugs have failed, the epilepsy is described as drug-resistant — and that term is not a verdict, it is a trigger: it is the point at which surgery and neurostimulation are assessed, not the point at which a third and a fourth drug are tried for years. This page sets out what each step involves and what it reasonably achieves.

The first drug, and what it is chosen for

The drug is chosen for the seizure type first, because the evidence for each medication is tied to the type of epilepsy it was studied in. A drug with good evidence in focal epilepsy is the natural first choice for a focal epilepsy, and the generalised epilepsies have their own set. This matters clinically and not just formally: several drugs that work well in focal epilepsy worsen absence and myoclonic seizures, and a person whose seizures are generalised can be made measurably worse by a drug that was reasonable for someone else.

The second set of considerations is about the person rather than the epilepsy. Age and sex, and whether pregnancy is possible, which brings the fetal risk associated with valproate into the discussion early rather than late; other medication and the interactions it creates, including with contraception; the person's work and whether sedation or slowed processing is acceptable; bone health and mood; and whether a drug is available and affordable where the person lives, which for a returning international patient is a practical part of the plan rather than an afterthought.

The way it is taken matters as much as which it is. Antiseizure medication is started at a low dose and increased gradually until seizures stop or side effects become limiting, which means the first weeks are not a fair test and a dose that made someone drowsy at the start is often tolerable once reached slowly. Missing doses is the commonest reason a drug appears to fail, and the reasons for missing them — a schedule that does not fit the day, side effects nobody asked about, cost — are all things that can be fixed without changing the prescription.

If the first does not work

Before a drug is called a failure, three questions are asked. Was the dose pushed to the limit of tolerance rather than abandoned at the first side effect. Was adherence good, including whether blood levels were checked where they are informative. And was the drug the right one for the seizure type in the first place. A meaningful proportion of "first drug failures" are one of those three, and the commonest is stopping early because of a side effect that would have settled.

Where the drug genuinely failed, the next step is usually a change to a different single drug rather than adding a second, because one drug at an adequate dose is easier to live with than two at inadequate doses, and because monotherapy is what the evidence supports most strongly. Some people do better on two drugs with different mechanisms, and that is a reasonable position when two single drugs have each partly worked. What is recorded either way is what was tried, at what dose, for how long and why it stopped — because that list is what the next doctor will be deciding from.

Drug-resistant epilepsy, and the number that defines it

Drug-resistant epilepsy is defined as the failure of two appropriately chosen and tolerated antiseizure medication schedules, whether as monotherapy or in combination, to achieve sustained freedom from seizures. The definition uses two, and it uses two for a reason that is worth stating plainly: the chance that a third drug achieves lasting freedom after two have failed is low, and each additional drug adds side effects and interactions while buying a small probability. That is why the number exists — to move the conversation, not to close it.

What follows the definition is not a new medication but a reassessment, and it has three parts. Confirm the diagnosis, because a proportion of people referred with drug-resistant epilepsy turn out on monitoring not to have epilepsy at all, or to have epilepsy together with functional non-epileptic attacks, and the treatment for that is not another drug. Look properly for a cause, with imaging read for epilepsy and with the immune and genetic questions asked where the course suggests them. And refer for a surgical opinion, because the assessment takes months and is best done while the person is younger and the brain has had less time to be shaped by years of seizures.

The delay is the part worth naming. The interval between drug resistance being established and a surgical opinion being given is measured in years in most health systems, and it is the single most modifiable thing in the whole condition. A comprehensive epilepsy centre — neurology, neurosurgery, neuroradiology, neuropsychology and psychiatric input in one programme — is where that assessment belongs, and an opinion from one is often the most useful thing an international patient can obtain before deciding anything else.

Surgery: removal, disconnection, and what it achieves

Resective surgery removes the region of brain where seizures begin. It is the treatment that offers the best chance of lasting freedom from seizures in drug-resistant focal epilepsy, and it is at its strongest in the situation where the cause is visible: temporal lobe epilepsy with hippocampal sclerosis, where a randomised trial conducted decades ago found surgery superior to continued medication, and where the result has been reproduced in practice ever since. The aim is not to reduce seizures but to stop them, and a substantial proportion of people who have it become free of the seizures they were having.

The work comes before the operation. A pre-surgical evaluation establishes where seizures begin and what removing that region would cost: long-term video EEG to capture events, MRI with an epilepsy protocol, neuropsychological testing to map memory and language, and sometimes PET, ictal SPECT or intracranial electrodes where the non-invasive studies disagree. It is also the stage at which the question of memory is taken seriously, because removing a hippocampus that is already scarred costs less than removing one that is still doing the work, and that is measured rather than assumed.

Where a single region cannot be safely removed, other operations exist and are used for specific purposes. Lesionectomy removes a discrete lesion such as a cavernous malformation or a low-grade tumour. Corpus callosotomy disconnects the hemispheres to stop the falls of atonic seizures, reducing the most dangerous events rather than all of them. Hemispherectomy or hemispherotomy, in a child with a large unilateral lesion and hemiplegia, removes or disconnects a hemisphere that is already not functioning, with a capacity for recovery of function that is remarkable in the young brain. None of these are first-line, and all of them are discussed with what they do and do not achieve stated explicitly.

Neurostimulation, for those who are not surgical candidates

Vagus nerve stimulation places a device under the skin of the chest with a lead to the vagus nerve in the neck, delivering stimulation on a cycle, with an additional mode triggered by the patient with a magnet when a seizure begins. Deep brain stimulation targets the anterior nucleus of the thalamus. Responsive neurostimulation detects the electrical activity at the onset of a seizure in the brain and stimulates in response, and also stores the recordings, which gives a continuous count of seizures rather than a diary. All three are used where resection is not possible or has not worked.

What they do is reduce the frequency and severity of seizures, and they do it progressively over months to years rather than immediately. They are not a cure, and they should never be presented as one; the improvement is real and measurable for many people, and it is described as a percentage reduction in seizures rather than as freedom from them. They also carry the obligations of an implanted device, including battery replacement and the question of MRI compatibility, which is worth raising before implantation rather than after.

Dietary treatment, and where it fits

The ketogenic diet is a high-fat, low-carbohydrate diet calculated and supervised by a specialist team, and it is used mainly in children with drug-resistant epilepsy. Modified versions, including the modified Atkins diet and the low glycaemic index treatment, are easier to sustain and are used in adolescents and adults as well. It requires a dietitian, monitoring, and a family or patient able to hold to it precisely, and it is stopped gradually rather than abruptly.

Two situations deserve naming. In specific metabolic conditions the diet is not an alternative treatment but the treatment: glucose transporter type 1 deficiency, for example, is managed with a ketogenic diet because it supplies the brain with an alternative fuel, and starting it early changes the developmental course. In the epileptic encephalopathies of infancy, dietary treatment is often tried alongside medication rather than after it has failed, because the cost of waiting is measured in development.

After control: what is reviewed, and what can be revisited

Once seizures stop, the questions change. How long medication continues, and whether it can be withdrawn — which is decided after a sustained seizure-free interval, with the seizure type, the EEG, the cause and any abnormality on imaging taken into account, and with the driving implications discussed before the decision rather than after it. Whether side effects that were accepted as the price of control are actually necessary, including effects on bone density, weight, mood and concentration that accumulate quietly over years.

The rest is what the seizures had been preventing. Driving, which is governed by a seizure-free interval set by law where the licence is held. Work, including at height, with machinery, and in safety-critical roles. Bathing and swimming, pregnancy and contraception, and the interaction between antiseizure medication and hormonal contraception. And mood, sleep and cognition, which are reviewed at every visit rather than left for the patient to raise, because depression and anxiety in epilepsy are common, treatable, and frequently missed when the consultation is only about the seizure count.

Frequently Asked Questions

If the first drug makes me tired, does that mean it is the wrong one?

Not necessarily. Tiredness, dizziness and difficulty concentrating are common when antiseizure medication is started or increased, and they often settle over the first weeks. That is why medication is started at a low dose and increased gradually. A side effect that persists at a dose that is stopping seizures is a reason to review, and can sometimes be managed by changing the timing, the formulation or the dose schedule rather than the drug.

Is surgery only for people with a visible lesion on the scan?

No. A visible lesion, particularly hippocampal sclerosis, is the favourable situation and the one with the strongest evidence. Surgery is also performed where the seizures begin in a region that can be identified electrically and removed safely, even when the MRI is normal, and that group does less well on average but includes people who become free of seizures. It is also worth knowing that a scan reported as normal elsewhere is sometimes re-read and found to show a lesion.

How long does the pre-surgical evaluation take?

Months rather than weeks, because it requires capturing several typical events on video EEG and completing imaging, neuropsychological testing and sometimes functional imaging or intracranial monitoring. It is run as a programme with a defined sequence rather than as a series of separate opinions, and it is the reason drug resistance should be recognised early: the assessment, not the operation, is what takes the time.

Can medication be stopped once seizures have been controlled for years?

It can, for some people, and the decision is individual rather than automatic. It is weighed after a sustained period without seizures, taking the syndrome, the EEG, the cause and the imaging into account, and taking the consequences of a relapse seriously — a licence, a job, and the fact that a withdrawal that fails usually means going back on medication. It is discussed with those specifics before it is started, and the dose is reduced slowly over months.

Ask whether drug resistance is established

Send the list of antiseizure drugs with the dose each reached, how long it was taken and why it stopped, together with the EEG reports, the imaging and whether it was read with an epilepsy protocol, and how often seizures happen now and in what pattern. A neurologist with an epilepsy interest will return a written opinion within about 48 hours of complete records arriving: whether the drugs tried count as two genuine failures, whether the cause has been looked for properly, whether a surgical evaluation is the right next step rather than another drug, and what that evaluation would involve and how long it takes.

Want to see the whole process first? Your full medical journey, step by step →

Book an Appointment Request a Video Consultation

Follow Fosun Health

Apply for an Appointment

Do you have test results*